Introduction Alopecia areata (AA) is a non-scarring, inflammatory condition characterized by loss of hair of the scalp and/or body. Objectives Novel alopecia areata therapeutic methods have being developed in order to improve care quality. This study will compare the fractionaed Er: YAG laser alone versus fractionated Er: YAG laser accompanied by local steroid in the treatment of alopecia areata. Methods Thirty people with alopecia areata participated in the study. In each participant, one lesion was handled by fractionated Er: YAG laser (laser group) and another one by fractionated Er: YAG laser followed by local clobetasol propionate (combined therapy group). The Severity of Alopecia Tool (SALT) score, satisfaction of participants, and dermoscopic signs were used to assess therapy response. Results Both treatment modalities resulted in a statistically significant decrease in the SALT score and a significant clinical improvement in alopecia areata. Concerning the combined therapy group, the SALT score was higher.